Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 323
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00150995 | Tetrathiomolybdate in Hormone Refractory Prostate Cancer | ||
| NCT06378398 | A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy | ||
| NCT07443943 | A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial | ||
| NCT03787680 | Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) | ||
| NCT00151086 | Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer | ||
| NCT00405327 | A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation | ||
| NCT03240016 | Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer | ||
| NCT04477200 | Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma | ||
| NCT00161265 | Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer | ||
| NCT04268134 | Altering Lipids for Tolerance of Aromatase Inhibitor Therapy | ||
| NCT02734797 | Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Transplant | ||
| NCT06941324 | Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors | ||
| NCT03235869 | Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma | ||
| NCT04431635 | Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma | ||
| NCT00242190 | Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer | ||
| NCT02496260 | Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy | ||
| NCT00615589 | Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen | ||
| NCT02784288 | Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer | ||
| NCT00580983 | Optimized Intensity Modulated Irradiation for Head and Neck Cancer | ||
| NCT01522937 | A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer | ||
| NCT03208712 | Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy | ||
| NCT00156286 | Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC | ||
| NCT05653388 | Metastatic Leiomyosarcoma Biomarker Protocol | ||
| NCT02997956 | Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE) | ||
| NCT02400190 | The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) | ||
| NCT00176735 | Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer | ||
| NCT04458168 | Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living | ||
| NCT02494453 | Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy | ||
| NCT00743509 | A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma | ||
| NCT02973711 | A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML | ||
| NCT05070299 | Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study | ||
| NCT00239200 | Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus | ||
| NCT01519219 | Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation | ||
| NCT00135187 | Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma | ||
| NCT00644696 | Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma | ||
| NCT02679586 | Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy | ||
| NCT00064272 | UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer | ||
| NCT05901519 | A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma | ||
| NCT00570531 | Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma | ||
| NCT01912612 | Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain | ||
| NCT05866302 | Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients | ||
| NCT00005598 | Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome | ||
| NCT03927105 | Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma | ||
| NCT03121287 | Early Imaging Biomarkers in NSCLC | ||
| NCT05867667 | Cardiac Rehabilitation to Improve Breast Cancer Outcomes | ||
| NCT00135200 | Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma | ||
| NCT07158021 | Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial | ||
| NCT01661114 | A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers | ||
| NCT03570619 | Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations | ||
| NCT04616651 | Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program |
